BarnaM.; UomoI.; PastorelloM. Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?. JOP. Journal of the Pancreas, v. 14, n. 1, p. 102-104, 10 jan. 2013.